Cargando…
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823002/ https://www.ncbi.nlm.nih.gov/pubmed/36609595 http://dx.doi.org/10.1038/s42003-022-04376-8 |
| _version_ | 1784866060108824576 |
|---|---|
| author | Kimmerling, Robert J. Stevens, Mark M. Olcum, Selim Minnah, Anthony Vacha, Madeleine LaBella, Rachel Ferri, Matthew Wasserman, Steven C. Fujii, Juanita Shaheen, Zayna Sundaresan, Srividya Ribadeneyra, Drew Jayabalan, David S. Agte, Sarita Aleman, Adolfo Criscitiello, Joseph A. Niesvizky, Ruben Luskin, Marlise R. Parekh, Samir Rosenbaum, Cara A. Tamrazi, Anobel Reid, Clifford A. |
| author_facet | Kimmerling, Robert J. Stevens, Mark M. Olcum, Selim Minnah, Anthony Vacha, Madeleine LaBella, Rachel Ferri, Matthew Wasserman, Steven C. Fujii, Juanita Shaheen, Zayna Sundaresan, Srividya Ribadeneyra, Drew Jayabalan, David S. Agte, Sarita Aleman, Adolfo Criscitiello, Joseph A. Niesvizky, Ruben Luskin, Marlise R. Parekh, Samir Rosenbaum, Cara A. Tamrazi, Anobel Reid, Clifford A. |
| author_sort | Kimmerling, Robert J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9823002 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98230022023-01-08 Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements Kimmerling, Robert J. Stevens, Mark M. Olcum, Selim Minnah, Anthony Vacha, Madeleine LaBella, Rachel Ferri, Matthew Wasserman, Steven C. Fujii, Juanita Shaheen, Zayna Sundaresan, Srividya Ribadeneyra, Drew Jayabalan, David S. Agte, Sarita Aleman, Adolfo Criscitiello, Joseph A. Niesvizky, Ruben Luskin, Marlise R. Parekh, Samir Rosenbaum, Cara A. Tamrazi, Anobel Reid, Clifford A. Commun Biol Publisher Correction Nature Publishing Group UK 2023-01-06 /pmc/articles/PMC9823002/ /pubmed/36609595 http://dx.doi.org/10.1038/s42003-022-04376-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Publisher Correction Kimmerling, Robert J. Stevens, Mark M. Olcum, Selim Minnah, Anthony Vacha, Madeleine LaBella, Rachel Ferri, Matthew Wasserman, Steven C. Fujii, Juanita Shaheen, Zayna Sundaresan, Srividya Ribadeneyra, Drew Jayabalan, David S. Agte, Sarita Aleman, Adolfo Criscitiello, Joseph A. Niesvizky, Ruben Luskin, Marlise R. Parekh, Samir Rosenbaum, Cara A. Tamrazi, Anobel Reid, Clifford A. Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_full | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_fullStr | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_full_unstemmed | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_short | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_sort | publisher correction: a pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823002/ https://www.ncbi.nlm.nih.gov/pubmed/36609595 http://dx.doi.org/10.1038/s42003-022-04376-8 |
| work_keys_str_mv | AT kimmerlingrobertj publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT stevensmarkm publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT olcumselim publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT minnahanthony publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT vachamadeleine publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT labellarachel publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT ferrimatthew publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT wassermanstevenc publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT fujiijuanita publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT shaheenzayna publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT sundaresansrividya publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT ribadeneyradrew publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT jayabalandavids publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT agtesarita publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT alemanadolfo publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT criscitiellojosepha publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT niesvizkyruben publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT luskinmarliser publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT parekhsamir publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT rosenbaumcaraa publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT tamrazianobel publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT reidclifforda publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements |